Skip to main content

Table 2 Toxicity profiles according to oxaliplatin dose levels

From: A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial)

 

Level 1 (n = 3)

 

Level 2 (n = 3)

 

Level 3 (n = 6)

 

NCI-CTCAE, version 3

G1/2

G3/4

G1/2

G3/4

G1/2

G3/4

Leukopenia

0/2

0/0

1/0

0/0

1/3

1/0

Neutropenia

0/1

0/0

0/0

0/0

0/2

1/0

Anemia

1/0

0/0

2/0

0/0

4/0

0/0

Thrombocytopenia

3/0

0/0

1/0

0/0

2/1

0/0

AST abnormalities

3/0

0/0

1/0

0/0

2/0

0/0

ALT abnormalities

2/1

0/0

1/0

0/0

3/0

0/0

Hyperbilirubinemia

0/0

0/0

0/1

0/0

1/0

0/0

Anorexia

0/0

0/0

1/2

0/0

1/0

0/0

Nausea

0/0

0/0

0/1

0/0

1/0

0/0

Fatigue

0/0

0/0

1/0

0/0

1/0

0/0

Alopecia

0/0

0/0

1/0

0/0

0/0

0/0

Diarrhea

2/0

0/0

1/1

0/0

3/0

0/0

Anorectal pain

0/0

0/0

0/0

0/0

0/0

0/0

Abdominal pain

0/0

0/0

1/0

0/0

0/0

0/0

Vein inflammation

0/0

0/0

0/2

0/0

0/0

0/0

Weight loss

1/1

0/0

1/0

0/0

0/0

0/0

Radiation rash

2/0

0/0

0/1

0/0

3/2

0/0

Sensory neuropathy

0/0

0/0

0/0

0/0

1/0

0/0

Hand-foot syndrome

0/0

0/0

0/0

0/0

0/0

0/0